Risks of Proton Pump Inhibitors in Patients with Cirrhosis: Please Peruse the Indications

被引：1
|
作者：
Low, En Xian Sarah [1 ]
Wang, Yen-Po [1 ,3 ]
Lu, Ching-Liang [1 ,2 ,3 ]
机构：
[1] Taipei Vet Gen Hosp, Endoscopy Ctr Diag & Treatment, Dept Med, Taipei, Taiwan
[2] Natl Yang Ming Chiao Tung Univ, Inst Brain Sci, Taipei, Taiwan
[3] Natl Yang Ming Chiao Tung Univ, Fac Med, Taipei, Taiwan
来源：
DIGESTIVE DISEASES AND SCIENCES | 2024年 / 69卷 / 01期
关键词：
Cirrhosis; Proton pump inhibitors; Hepatocellular carcinoma; Hepatic decompensation; Spontaneous bacterial peritonitis;
D O I：
10.1007/s10620-023-08153-3
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
The use of proton pump inhibitor (PPI) in cirrhotic patients can be associated with increased risks of long-term mortality, decompensation, hepatic encephalopathy, spontaneous bacterial peritonitis, and infection, but not with short-term mortality. Ensure clear indications at lowest effective dose of is mandatory for the use of PPI among cirrhotic patients.
引用
收藏
页码：7 / 9
页数：3
相关论文
共 50 条
  • [21] Balancing the Risks and Benefits of Proton Pump Inhibitors
    Gill, James M.
    Player, Marty S.
    Metz, David C.
    ANNALS OF FAMILY MEDICINE, 2011, 9 (03) : 200 - 202
  • [22] Introduction - Proton pump inhibitors: gastrointestinal indications and beyond
    Arvanitakis, C
    Blum, A
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2002, 14 : S3 - S4
  • [23] Effect of Proton Pump Inhibitors on Mortality in Patients with Cirrhosis and Spontaneous Bacterial Peritonitis
    Hung, Tsung-Hsing
    Tseng, Chih-Wei
    Lee, Hsing-Feng
    Tsai, Chih-Chun
    Tsai, Chen-Chi
    ANNALS OF HEPATOLOGY, 2018, 17 (06) : 933 - 939
  • [24] Subsequent Bacterial Infections in Patients With Cirrhosis and the Role of Proton-Pump Inhibitors
    Sargenti, Konstantina
    Kalaitzakis, Evangelos
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (11) : 2026 - 2027
  • [25] Letter: proton pump inhibitors - severity of liver disease and mortality in patients with cirrhosis
    Lin, Su
    Dong, Jing
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (07) : 704 - 705
  • [26] Effect of proton pump inhibitors on the risk and prognosis of infections in patients with cirrhosis and ascites
    Dam, Gitte
    Vilstrup, Hendrik
    Andersen, Per Kragh
    Bossen, Lars
    Watson, Hugh
    Jepsen, Peter
    LIVER INTERNATIONAL, 2019, 39 (03) : 514 - 521
  • [27] Proton pump inhibitors increase the risk for hepatic encephalopathy in patients with cirrhosis and ascites
    Matei, D.
    Pasca, S.
    David, A.
    Procopet, B.
    Stefanescu, H.
    Vesa, S.
    Andreica, V.
    Tantau, M.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S136 - S136
  • [28] The Use of Proton Pump Inhibitors in Patients with Liver Cirrhosis: Real Life Experience
    Spitz, Raphael Eftimie
    Popa, Stefan Lucian
    Grad, Simona
    Dumitrascu, Dan Lucian
    Ismaiel, Abdulrahman
    Surdea-Blaga, Teodora
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (17)
  • [29] Infection risk and management strategies for patients with cirrhosis taking proton pump inhibitors
    Zerr, Beth
    Vazquez, Alejandro
    Erstad, Brian L.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2023, 80 (15) : 967 - 973
  • [30] Proton pump inhibitors in patients with liver cirrhosis - a survey among hepatologists in Germany
    Horvatits, Thomas
    Drolz, Andreas
    Wehmeyer, Malte
    Steib, Christian
    Trebicka, Jonel
    Lohse, Ansgar W.
    Kluwe, Johannes
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2019, 57 (06): : 729 - 733
12345